lin-17 : lrp-2

"Expression of egl-20 from the center of the axis of symmetry partially suppresses the lin-17(n671) phenotype (Green et al., 2008; Table 1)."

Interaction involving unc-45

"The WT protein appears to dimerize through interactions between the first armadillo repeat. In contrast, the model for the DEL dimer indicates that the interaction interface has moved toward the center of the domain."

pgl-1 : spd-5

P granules localize to the posterior prior to the first mitosis in wild-type embryos, but are often found in the center of spd-5 embryos (early one-cell stage). P granules often do become restricted to the posterior abnormally late in spd-5 mutants.

mei-1 : mei-2

"ectopic MEI-2(+) staining was also observed during mitosis in the mei-1(ct46gf) mutant background (Fig. 6D-I). Specifically, anti-MEI-2 was detected within the MT-free zone at the center of the centrosomes and with condensed mitotic chromatin from metaphase to anaphase, in a pattern identical to MEI-1 (see below and Fig. 7)."

mei-1 : mei-2

"ectopic MEI-2(+) staining was also observed during mitosis in the mei-1(ct46gf) mutant background (Fig. 6D-I). Specifically, anti-MEI-2 was detected within the MT-free zone at the center of the centrosomes and with condensed mitotic chromatin from metaphase to anaphase, in a pattern identical to MEI-1 (see below and Fig. 7)."

cki-1 : pat-3

In contrast to the compact, nucleolar staining seen in pat-3(+) animals, CKI- 1::GFP in pat-3(sp) was clumped and accumulated in a ring around a dark center in the nucleus, suggesting mislocalization and possible exclusion from the nucleolus. In addition, the intensity of green fluorescence in pat-3(sp) was increased compared to pat-3(+). CKI-1::GFP level in pat-3(sp) was ten fold more intense than that seen in pat-3(+) lysates.

sas-4 : zyg-1 : zyg-9

"we examined the distribution of two putative centriolar markers, ZYG-1 and the Polo-like kinase PLK-1. In wild-type, antibodies against both proteins identify a tiny dot in the center of centrosomes, suggesting that ZYG-1 and PLK-1 are present at centrioles or a closely associated structure (Figures 2G-2I and data not shown... Using both markers, we found that the PCM in sas-4(RNAi) embryos at the two-cell stage harbors a single ZYG-1 and PLK-1-containing entity, the size of which does not exceed that observed in wild-type (Figures 2J-2L and data not shown)."

pat-3 : pat-6

"In wild-type ~500 min embryos, PAT-6/actopaxin is polarized and located in nascent attachment complexes within the basal sarcolemma (arrow, Figure 4B1). In contrast, when we remove UNC-52/perlecan, PAT-3/integrin, UNC-112, or PAT-4/ILK, the recruitment of PAT-6/actopaxin to muscle attachments is disrupted. In the unc-52, pat-3, and unc-112 mutants, PAT-6/actopaxin is located in small puncta within the muscle cell cytoplasm (small arrows, Figures 4B2-4B4). A cell nucleus (labeled "n") occasionally appears as a round, non-stained region in the center of a body wall muscle cell in these embryos... we are not able to detect any PAT-6/actopaxin in pat-4 mutants (n > 200) (Figure 4B5). MH27 stains the hypodermal cell junctions (arrowheads) of these animals, however, confirming antibody penetration. "

pat-6 : unc-52

"In wild-type ~500 min embryos, PAT-6/actopaxin is polarized and located in nascent attachment complexes within the basal sarcolemma (arrow, Figure 4B1). In contrast, when we remove UNC-52/perlecan, PAT-3/integrin, UNC-112, or PAT-4/ILK, the recruitment of PAT-6/actopaxin to muscle attachments is disrupted. In the unc-52, pat-3, and unc-112 mutants, PAT-6/actopaxin is located in small puncta within the muscle cell cytoplasm (small arrows, Figures 4B2-4B4). A cell nucleus (labeled "n") occasionally appears as a round, non-stained region in the center of a body wall muscle cell in these embryos... we are not able to detect any PAT-6/actopaxin in pat-4 mutants (n > 200) (Figure 4B5). MH27 stains the hypodermal cell junctions (arrowheads) of these animals, however, confirming antibody penetration. "

pat-4 : pat-6

"In wild-type ~500 min embryos, PAT-6/actopaxin is polarized and located in nascent attachment complexes within the basal sarcolemma (arrow, Figure 4B1). In contrast, when we remove UNC-52/perlecan, PAT-3/integrin, UNC-112, or PAT-4/ILK, the recruitment of PAT-6/actopaxin to muscle attachments is disrupted. In the unc-52, pat-3, and unc-112 mutants, PAT-6/actopaxin is located in small puncta within the muscle cell cytoplasm (small arrows, Figures 4B2-4B4). A cell nucleus (labeled "n") occasionally appears as a round, non-stained region in the center of a body wall muscle cell in these embryos... we are not able to detect any PAT-6/actopaxin in pat-4 mutants (n > 200) (Figure 4B5). MH27 stains the hypodermal cell junctions (arrowheads) of these animals, however, confirming antibody penetration. "